company, which is principally engaged in the manufacture of skincare products, cosmetics, food supplements and medicines used to treat skin diseases. The Company paid 20 million to the seller in December
this company, which is principally engaged in the manufacture of skincare products, cosmetics, food supplements and medicines used to treat skin diseases. The Company paid 20 million to the seller in
% -2.1% - Basic earnings per share (Baht/share) 0.03 0.06 0.05 0.07 (0.03) (56.8) Net profit margin 3.1% 6.6% 5.8% 7.4% -3.5% - Page 2 of 11 Sales and service income Table 2 : Sales by Product Type for
sales 6.1% 7.5% (1.4%) 5.7% 7.1% (1.4%) Administrative expense per net sales 10.5% 12.5% (2.0%) 8.6% 9.8% (1.2%) Net profit margin 4.4% 3.1% 1.3% 6.7% 5.8% 0.9% Earnings per share (Bath/Share) 0.05 0.03
business strategies as follows: - Focus on sales online channels. - Increasing direct sales channels. - Manufacture of fabric masks to increase sales channels. Revenue by type - The sales Revenue of Sabina
remaining two segments, Integrated Oxides & Derivatives and Specialty Chemicals are expected to resume their earnings from unplanned shutdowns, except IPA which we believe will recover over the next 12-18
6661 Fax: +662 661 6664 Indorama Ventures 2018 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis For the year ended December 31, 2018 Milestone Revenues and Earnings
Quarter 2018 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 3rd Quarter 2018 Milestone Revenues and Earnings, Structural Improvements, Enhanced Portfolio and Geographic Reach
interest in a subsidiary by Baht 10.18 million, decreased by Baht 3.41 million from the same period of previous year due to the decrease in net profit of a subsidiary company who manufacture and supply the